TherapeuticsMD (TXMD) Operating Leases (2012 - 2026)
TherapeuticsMD (TXMD) reported Operating Leases of $4.52 million for Q2 2026, down 20.9% from $5.72 million a year earlier and down 6.3% from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Operating Leases (2012 - 2026) Analysis & Trends
At the end of FY2025, TherapeuticsMD posted Operating Leases of $5.12 million, down 7.6% from FY2024.
- Operating Leases has declined for six consecutive years, with a five-year compound annual growth rate of -10.0% (FY2020 to FY2025).
- By year, Operating Leases came in at $5.54 million in FY2024 (-15.2%), $6.53 million in FY2023 (-11.4%), $7.37 million in FY2022 (-8.6%) and $8.06 million in FY2021 (-7.1%).
- The Q2 2026 figure ranks as the lowest quarterly Operating Leases since Q2 2019.
- Year over year, Operating Leases has now declined in each of the last four quarters, with an average decline of 13.9% over the last six quarters.
- The year-over-year decline in Operating Leases has ranged between 6.3% (Q3 2025) and 20.9% (Q2 2026) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.82 million (Q1 2026), $5.12 million (Q4 2025) and $5.41 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | TherapeuticsMD | 20.14 Mn | -12.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.52 Mn |
| Mar 31, 2026 | 4.82 Mn |
| Dec 31, 2025 | 5.12 Mn |
| Sep 30, 2025 | 5.41 Mn |
| Jun 30, 2025 | 5.72 Mn |
| Mar 31, 2025 | 5.96 Mn |
| Dec 31, 2024 | 5.54 Mn |
| Sep 30, 2024 | 5.78 Mn |
| Jun 30, 2024 | 6.00 Mn |
| Mar 31, 2024 | 6.32 Mn |
| Dec 31, 2023 | 6.53 Mn |
| Sep 30, 2023 | 6.74 Mn |
| Jun 30, 2023 | 6.94 Mn |
| Mar 31, 2023 | 7.14 Mn |
| Dec 31, 2022 | 7.37 Mn |
| Sep 30, 2022 | 7.55 Mn |
| Jun 30, 2022 | 7.73 Mn |
| Mar 31, 2022 | 7.90 Mn |
| Dec 31, 2021 | 8.06 Mn |
| Sep 30, 2021 | 8.23 Mn |
API Access
TherapeuticsMD Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();